Home Healthcare Pharmaceuticals Gastrointestinal Therapeutics Market

Gastrointestinal Therapeutics Market Size, Share & Trends Analysis Report By Product (OTC Gastrointestinal Therapeutics, Prescription-Based Gastrointestinal Therapeutics), By Application (Irritable Bowel Syndrome, Peptic Ulcer Disease (PUD), Gastroenteritis, GI Bleeding, Others), By End-Users (Hospitals, Clinics, Others), By Dosage Form (Injections, Oral) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Debashree B | Format: | Report Code: SR2634DR | Pages: 156
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Gastrointestinal Therapeutics Market, By Product 2022-2034 (USD MILLION/ Units)
    1. OTC Gastrointestinal Therapeutics
    2. Prescription-Based Gastrointestinal Therapeutics
  2. Gastrointestinal Therapeutics Market, By Application 2022-2034 (USD MILLION/ Units)
    1. Irritable Bowel Syndrome
    2. Peptic Ulcer Disease (PUD)
    3. Gastroenteritis
    4. GI Bleeding
    5. Others
  3. Gastrointestinal Therapeutics Market, By End-Users 2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Clinics
    3. Others
  4. Gastrointestinal Therapeutics Market, By Dosage Form 2022-2034 (USD MILLION/ Units)
    1. Injections
    2. Oral
  5. Regional Gastrointestinal Therapeutics Market
    1. North America
      1. North America Gastrointestinal Therapeutics Market By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      2. North America Gastrointestinal Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      3. North America Gastrointestinal Therapeutics Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. North America Gastrointestinal Therapeutics Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
      5. U.S.
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      6. Canada
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
    2. Europe
      1. Europe Gastrointestinal Therapeutics Market By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      2. Europe Gastrointestinal Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      3. Europe Gastrointestinal Therapeutics Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. Europe Gastrointestinal Therapeutics Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
      5. U.K.
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      6. Germany
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      7. France
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      8. Spain
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      9. Italy
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      10. Russia
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      11. Nordic
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      12. Benelux
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      13. Rest of Europe
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
    3. APAC
      1. APAC Gastrointestinal Therapeutics Market By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      2. APAC Gastrointestinal Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      3. APAC Gastrointestinal Therapeutics Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. APAC Gastrointestinal Therapeutics Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
      5. China
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      6. Korea
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      7. Japan
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      8. India
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      9. Australia
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      10. Taiwan
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      11. South East Asia
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      12. Rest of Asia-Pacific
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
    4. Middle East and Africa
      1. Middle East and Africa Gastrointestinal Therapeutics Market By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      2. Middle East and Africa Gastrointestinal Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      3. Middle East and Africa Gastrointestinal Therapeutics Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. Middle East and Africa Gastrointestinal Therapeutics Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
      5. UAE
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      6. Turkey
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      7. Saudi Arabia
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      8. South Africa
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      9. Egypt
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      10. Nigeria
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      11. Rest of MEA
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
    5. LATAM
      1. LATAM Gastrointestinal Therapeutics Market By Product 2022-2034 (USD MILLION/ Units)
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
      2. LATAM Gastrointestinal Therapeutics Market By Application 2022-2034 (USD MILLION/ Units)
        1. Irritable Bowel Syndrome
        2. Peptic Ulcer Disease (PUD)
        3. Gastroenteritis
        4. GI Bleeding
        5. Others
      3. LATAM Gastrointestinal Therapeutics Market By End-Users 2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Clinics
        3. Others
      4. LATAM Gastrointestinal Therapeutics Market By Dosage Form 2022-2034 (USD MILLION/ Units)
        1. Injections
        2. Oral
      5. Brazil
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      6. Mexico
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      7. Argentina
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      8. Chile
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      9. Colombia
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
      10. Rest of LATAM
        1. OTC Gastrointestinal Therapeutics
        2. Prescription-Based Gastrointestinal Therapeutics
        3. Irritable Bowel Syndrome
        4. Peptic Ulcer Disease (PUD)
        5. Gastroenteritis
        6. GI Bleeding
        7. Others
        8. Hospitals
        9. Clinics
        10. Others
        11. Injections
        12. Oral
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.